Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 32.64
(0.02%)
AUD 32.64
(0.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 444.8 Million NZD | 2.56% |
| 2023 | 433.7 Million NZD | -21.16% |
| 2022 | 605.1 Million NZD | -26.85% |
| 2021 | 808.2 Million NZD | 63.34% |
| 2020 | 435.4 Million NZD | 28.1% |
| 2019 | 337.6 Million NZD | 17.2% |
| 2018 | 290.32 Million NZD | 27.1% |
| 2017 | 275.9 Million NZD | 3.6% |
| 2016 | 220.48 Million NZD | 9.22% |
| 2015 | 201.87 Million NZD | 15.8% |
| 2014 | 174.33 Million NZD | 23.91% |
| 2013 | 137.84 Million NZD | 21.67% |
| 2012 | 115.63 Million NZD | -3.95% |
| 2011 | 120.39 Million NZD | -0.46% |
| 2010 | 120.94 Million NZD | -0.01% |
| 2009 | 120.95 Million NZD | 61.07% |
| 2008 | 74.34 Million NZD | -27.57% |
| 2007 | 103.68 Million NZD | -9.65% |
| 2006 | 114.76 Million NZD | 13.91% |
| 2005 | 100.74 Million NZD | 12.24% |
| 2004 | 89.76 Million NZD | -25.27% |
| 2003 | 120.11 Million NZD | 17.87% |
| 2002 | 101.9 Million NZD | 310.39% |
| 2001 | 24.83 Million NZD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 246.4 Million NZD | 0.0% |
| 2024 FY | - NZD | -10.33% |
| 2024 Q2 | 198.4 Million NZD | 0.0% |
| 2023 FY | - NZD | -21.16% |
| 2023 Q4 | 240 Million NZD | 0.0% |
| 2023 Q2 | 169.5 Million NZD | 0.0% |
| 2022 Q4 | 236.8 Million NZD | 0.0% |
| 2022 Q2 | 341.7 Million NZD | 0.0% |
| 2022 FY | - NZD | -26.85% |
| 2021 FY | - NZD | 63.34% |
| 2021 Q4 | 440.1 Million NZD | 0.0% |
| 2021 Q2 | 341.2 Million NZD | 0.0% |
| 2020 Q4 | 235.8 Million NZD | 0.0% |
| 2020 Q2 | 189.8 Million NZD | 0.0% |
| 2020 FY | - NZD | 28.1% |
| 2019 Q4 | 186.2 Million NZD | 0.0% |
| 2019 FY | - NZD | 17.2% |
| 2019 Q2 | 167.6 Million NZD | 0.0% |
| 2018 Q4 | 172.3 Million NZD | 0.0% |
| 2018 FY | - NZD | 27.1% |
| 2018 Q2 | 138.5 Million NZD | 0.0% |
| 2017 Q4 | 145.3 Million NZD | 0.0% |
| 2017 FY | - NZD | 3.6% |
| 2017 Q2 | 130.6 Million NZD | 0.0% |
| 2016 Q2 | 111.55 Million NZD | 0.0% |
| 2016 FY | - NZD | 9.22% |
| 2016 Q4 | 132.13 Million NZD | 0.0% |
| 2015 FY | - NZD | 15.8% |
| 2015 Q4 | 111.61 Million NZD | 0.0% |
| 2015 Q2 | 88.29 Million NZD | 0.0% |
| 2014 Q3 | 43.12 Million NZD | -47.03% |
| 2014 Q4 | 90.47 Million NZD | 109.81% |
| 2014 Q1 | 33.86 Million NZD | -56.16% |
| 2014 FY | - NZD | 23.91% |
| 2014 Q2 | 81.4 Million NZD | 140.34% |
| 2013 Q1 | 28.6 Million NZD | 0.0% |
| 2013 Q2 | 28.6 Million NZD | 0.0% |
| 2013 Q3 | 33.86 Million NZD | 18.4% |
| 2013 FY | - NZD | 21.67% |
| 2013 Q4 | 77.25 Million NZD | 128.1% |
| 2012 Q4 | 28.6 Million NZD | 0.0% |
| 2012 FY | - NZD | -3.95% |
| 2012 Q3 | 28.6 Million NZD | -0.12% |
| 2012 Q2 | 28.63 Million NZD | 0.0% |
| 2012 Q1 | 28.63 Million NZD | 0.0% |
| 2011 Q4 | 28.63 Million NZD | 0.0% |
| 2011 Q1 | 29.25 Million NZD | 0.0% |
| 2011 Q3 | 28.63 Million NZD | -2.1% |
| 2011 FY | - NZD | -0.46% |
| 2011 Q2 | 29.25 Million NZD | 0.0% |
| 2010 Q4 | 29.25 Million NZD | 0.0% |
| 2010 FY | - NZD | -0.01% |
| 2010 Q1 | 29.49 Million NZD | 0.0% |
| 2010 Q2 | 29.49 Million NZD | 0.0% |
| 2010 Q3 | 29.25 Million NZD | -0.8% |
| 2009 FY | - NZD | 61.07% |
| 2009 Q4 | 29.49 Million NZD | 0.0% |
| 2009 Q2 | 18.22 Million NZD | 0.0% |
| 2009 Q1 | 18.22 Million NZD | 0.0% |
| 2009 Q3 | 29.49 Million NZD | 61.8% |
| 2008 Q2 | 22.6 Million NZD | 0.0% |
| 2008 Q4 | 18.22 Million NZD | 0.0% |
| 2008 Q1 | 22.6 Million NZD | 0.0% |
| 2008 FY | - NZD | -27.57% |
| 2008 Q3 | 18.22 Million NZD | -19.38% |
| 2007 Q4 | 22.6 Million NZD | 0.0% |
| 2007 Q1 | 28.69 Million NZD | 0.0% |
| 2007 Q2 | 28.69 Million NZD | 0.0% |
| 2007 Q3 | 22.6 Million NZD | -21.2% |
| 2007 FY | - NZD | -9.65% |
| 2006 Q1 | 40.36 Million NZD | 0.0% |
| 2006 Q4 | 28.69 Million NZD | 0.0% |
| 2006 FY | - NZD | 13.91% |
| 2006 Q3 | 28.69 Million NZD | -28.92% |
| 2006 Q2 | 40.36 Million NZD | 0.0% |
| 2005 Q3 | 40.36 Million NZD | 12.6% |
| 2005 Q2 | 35.84 Million NZD | 0.0% |
| 2005 Q1 | 35.84 Million NZD | 0.0% |
| 2005 Q4 | 40.36 Million NZD | 0.0% |
| 2005 FY | - NZD | 12.24% |
| 2004 Q1 | 46.14 Million NZD | 0.0% |
| 2004 Q2 | 46.14 Million NZD | 0.0% |
| 2004 Q3 | 35.84 Million NZD | -22.31% |
| 2004 Q4 | 35.84 Million NZD | 0.0% |
| 2004 FY | - NZD | -25.27% |
| 2003 Q1 | 21.83 Million NZD | 0.0% |
| 2003 Q3 | 46.14 Million NZD | 111.36% |
| 2003 FY | - NZD | 17.87% |
| 2003 Q4 | 46.14 Million NZD | 0.0% |
| 2003 Q2 | 21.83 Million NZD | 0.0% |
| 2002 Q1 | 8.63 Million NZD | 0.0% |
| 2002 FY | - NZD | 310.39% |
| 2002 Q4 | 21.83 Million NZD | 0.0% |
| 2002 Q3 | 21.83 Million NZD | 152.83% |
| 2002 Q2 | 8.63 Million NZD | 0.0% |
| 2001 Q3 | 8.63 Million NZD | 0.0% |
| 2001 FY | - NZD | 0.0% |
| 2001 Q4 | 8.63 Million NZD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Austco Healthcare Limited | 8.11 Million AUD | -5381.883% |
| Nanosonics Limited | 21.72 Million AUD | -1947.599% |
| Osteopore Limited | -4.34 Million AUD | 10327.599% |
| SDI Limited | 20.96 Million AUD | -2022.137% |
| Trajan Group Holdings Limited | -20.35 Million AUD | 2284.998% |